- tags:Glance Videos
Products
Luminopia ranks among best inventions of 2023
The binocular digital platform is the first therapy for treating visual acuity in pediatric amblyopia patients.Research
EyeCorps nonprofit seeks to end preventable blindness in Africa
Co-founder Susan MacDonald, MD, discusses addressing the gaps in eyecare and an upcoming trip to educate and train ophthalmology professionals.Products
Positive 24-month data released for phase 3 trials on Syfovre
Latest data supports the FDA-approved therapeutic for treating GA.Products
Bausch + Lomb launches enVista Aspire IOL in the US
New IOL addition to the enVista family treats lower levels of astigmatism with optimized extended range of vision.Products
FDA approves Orasis's QLOSI for presbyopia
The preservative-free, low-dose eye drop will be commercially available in 2024.Research
Managing ocular emergencies as an on-call optometrist
Jessilin Quint, OD, MS, FAAO, offers clinicians a sneak peek of her Vision Expo West presentation.Research
What to rule out before diagnosing DED
Mile Brujic, OD, FAAO, offers clinicians a sneak peek of his Vision Expo West presentation.Products
HOYA Vision Care introduces anti-reflective lens coating technology
Latest AR treatment is designed with 2.5 times more scratch resistance and 56% lower reflectance.Research
Advancing the understanding of geographic atrophy
Mark Dunbar, OD, FAAO, offers clinicians a sneak peek of his Vision Expo West presentation.Research
How to medically manage anterior segment disease
Marc Bloomenstein, OD, FAAO, offers clinicians a sneak peek of his Vision Expo West presentation.Products
IYUZEH launches in the United States
Preservative-free formulation targets elevated IOP in OAG and OHT patients.Research
iDetective campaign targets early keratoconus diagnosis
Optometrist-focused initiative advocates for game-changing patient care.Products
Long-term visual outcomes support remote AMD monitoring
Ten-year study reported positive data for Notal Vision’s ForeseeHome program.Research
Preservative Freedom Coalition is targeting ocular surface awareness
Launched by Théa Pharma, the organization advocates for improved patient outcomes and ensuring access to safe and effective preservative-free treatment options.Products
FDA approves Tarsus’s XDEMVY for Demodex blepharitis
Formerly known as TP-03, approval is the first that directly targets the root cause of the disease.Research
Are Zepto PPC and CCC comparable in phaco cataract surgery?
Investigators assess the extent of endothelial cell density loss postoperatively.Research
Eyes On Eyecare announces the launch of Courses
On-demand content provides 24/7 access to continuing education for optometrists.Pipeline
LumiThera reports 24-month data from LIGHTSITE III trial for dry AMD
Following initial data, latest results support the use of the Valeda Light Delivery System.Products